Chapter 1. Market Scope and Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Biochips Market, by Product
1.4.2 North America Biochips Market, by Application
1.4.3 North America Biochips Market, by End User
1.4.4 North America Biochips Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Biochips Market by Product
3.1 North America DNA Chip Market by Country
3.2 North America Protein Chip Market by Country
3.3 North America Lab-on-Chip Market by Country
3.4 North America Other Products Market by Country
Chapter 4. North America Biochips Market by Application
4.1 North America Drug Discovery and Development Market by Country
4.2 North America Disease Diagnostics Market by Country
4.3 North America Genomics Market by Country
4.4 North America Proteomics Market by Country
4.5 North America Agriculture Market by Country
4.6 North America Other Applications Market by Country
Chapter 5. North America Biochips Market by End User
5.1 North America Biotechnology and Pharmaceutical Sector Market by Country
5.2 North America Hospitals and Diagnostics Centers Market by Country
5.3 North America Academic and Research Institutes Market by Country
5.4 North America Other End Users Market by Country
Chapter 6. North America Biochips Market by Country
6.1 USA Biochips Market
6.1.1 USA Biochips Market by Product
6.1.2 USA Biochips Market by Application
6.1.3 USA Biochips Market by End User
6.2 Canada Biochips Market
6.2.1 Canada Biochips Market by Product
6.2.2 Canada Biochips Market by Application
6.2.3 Canada Biochips Market by End User
6.3 Mexico Biochips Market
6.3.1 Mexico Biochips Market by Product
6.3.2 Mexico Biochips Market by Application
6.3.3 Mexico Biochips Market by End User
6.4 Rest of North America Biochips Market
6.4.1 Rest of North America Biochips Market by Product
6.4.2 Rest of North America Biochips Market by Application
6.4.3 Rest of North America Biochips Market by End User
Chapter 7. Company Profiles
7.1 Fluidigm Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research and Development Expense
7.2 Horiba Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research and Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and mergers:
7.3 PerkinElmer, Inc.
7.3.1 Company Overview
7.3.1 Financial Analysis
7.3.2 Segmental and Regional Analysis
7.3.3 Research and Development Expense
7.3.4 Recent strategies and developments:
7.3.4.1 Acquisition and mergers:
7.3.4.2 Product launches:
7.4 OriGene Technologies, Inc.
7.4.1 Company Overview
7.5 Dynamic Biosensors GmbH
7.5.1 Company Overview
7.6 Illumina, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research and Development Expense
7.7 Qiagen N.V.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research and Development Expense
7.8 Bio-Rad laboratories, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research and Development Expenses
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and mergers:
7.9 Randox Laboratories Limited
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Collaborations, partnerships and agreements:
7.9.2.2 Product launches:
7.1 Thermo Fischer Scientific, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research and Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Collaborations, partnerships and agreements:
Unique Offerings 
